Could 10, 2022
1 min learn
The FDA has restricted the usage of Johnson & Johnson’s COVID-19 vaccine because of its affiliation with thrombosis with thrombocytopenia syndrome.
The vaccine can be accessible to adults who shouldn’t have entry to different COVID-19 vaccines and people who elect to solely obtain the Johnson & Johnson vaccine and would in any other case be unvaccinated, in response to the FDA. It was the highest story in infectious illness final week.
The second high story was about lengthy COVID and new knowledge that present greater than 200 million folks globally are affected by COVID-19’s long-term results.
Learn the highest tales in infectious illness beneath:
FDA restricts use of Johnson & Johnson COVID-19 vaccine
The FDA has restricted the usage of Johnson & Johnson’s COVID-19 vaccine based mostly on an up to date evaluation of the danger for a uncommon however doubtlessly lethal blood-clotting syndrome. Read more.
World prevalence of lengthy COVID ‘substantial,’ researchers say
Researchers estimated that greater than 200 million folks globally endure from long-term results of COVID-19, in response to a current research. Read more.
COVID-19 related to practically 15 million extra deaths, WHO finds
Almost 15 million folks died as a direct or oblique results of COVID-19 in the course of the first 24 months of the pandemic, in response to a brand new estimate revealed Thursday by WHO. Read more.
Stewardship bundle ‘dramatically’ decreases fluoroquinolone use in UTIs
An antimicrobial stewardship bundle carried out at practically two dozen pressing and first care clinics in Florida resulted in a dramatic lower in fluoroquinolone use for UTIs, researchers reported. Read more.
Vertical hepatitis C transmission extra frequent than assumed, research finds
The speed of vertical hepatitis C transmission is almost 25% greater than generally assumed, in response to a reanalysis of information from greater than 1,700 kids born to moms contaminated with the virus. Read more.